Total Visits

Views
The ... 493

Total Visits Per Month

October 2024November 2024December 2024January 2025February 2025March 2025April 2025
The ... 4 8 9 3 5 12 0

File Visits

Views
The Cardiovascular Benefits of Empagliflozin, A Sodium Glucose Cotransporter Inhibitor Is NHE1 a Viable Target.pdf 212

Top country views

Views
United States 242
China 45
Singapore 27
Taiwan 16
Japan 14
Qatar 12
Ireland 10
Argentina 9
Egypt 9
United Kingdom 9

Top cities views

Views
Colorado Springs 48
Ashburn 37
Sherman Oaks 17
Taipei 12
Oakland 11
Doha 10
Dublin 10
Shanghai 10
Giza 8
Beijing 6